dostęp otwarty
Pregnancy-associated breast cancer as a screening and diagnostic challenge: a case report
Afiliacje- Department of Electroradiology, Greater Poland Cancer Center, Poznan, Poland
dostęp otwarty
Streszczenie
Pregnancy-associated breast cancer (PABC) is the most common malignancy of pregnancy, affecting 1 in 3000 women. Due to the increased size and density of the breast tissue during pregnancy and lactation, diagnosis and treatment are commonly delayed. A 37-year-old woman, gravida 1 para 0, at the 27th week of gestation presented with two tumors of approximately 2 cm in the right breast with ipsilateral lymph node involvement on the ultrasonography. HER2–, ER+, PR+, a poorly differentiated ductal carcinoma was identified by the core biopsy and immunohistochemistry. The diagnosis of PABC was made, the tumor’s clinical stage was cT2, N1, Mx. She underwent a total mastectomy with axillary node dissection on the right side and was started on adjuvant therapy with paclitaxel. Our report highlights the importance of proper breast oncology surveillance during pregnancy, using safe and inexpensive methods including ultrasonography and biopsy of suspicious masses, to avoid cancer development and progression.
Streszczenie
Pregnancy-associated breast cancer (PABC) is the most common malignancy of pregnancy, affecting 1 in 3000 women. Due to the increased size and density of the breast tissue during pregnancy and lactation, diagnosis and treatment are commonly delayed. A 37-year-old woman, gravida 1 para 0, at the 27th week of gestation presented with two tumors of approximately 2 cm in the right breast with ipsilateral lymph node involvement on the ultrasonography. HER2–, ER+, PR+, a poorly differentiated ductal carcinoma was identified by the core biopsy and immunohistochemistry. The diagnosis of PABC was made, the tumor’s clinical stage was cT2, N1, Mx. She underwent a total mastectomy with axillary node dissection on the right side and was started on adjuvant therapy with paclitaxel. Our report highlights the importance of proper breast oncology surveillance during pregnancy, using safe and inexpensive methods including ultrasonography and biopsy of suspicious masses, to avoid cancer development and progression.
Słowa kluczowe
breast neoplasms; pregnancy; diagnosis
Informacje o artykuleTytuł
Pregnancy-associated breast cancer as a screening and diagnostic challenge: a case report
Czasopismo
Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory
Numer
Typ artykułu
Opis przypadku
Strony
211-213
Opublikowany online
2021-02-10
Wyświetlenia strony
201
Wyświetlenia/pobrania artykułu
164
Rekord bibliograficzny
Biuletyn Polskiego Towarzystwa Onkologicznego Nowotwory 2021;6(3):211-213.
Słowa kluczowe
breast neoplasms
pregnancy
diagnosis
Autorzy
Anastasia Kalantarova
Nicole Josephine Zembol
Joanna Kufel-Grabowska
Referencje (18)- Molckovsky A, Madarnas Y. Breast cancer in pregnancy: a literature review. Breast Cancer Res Treat. 2008; 108(3): 333–338.
- Beadle B, Woodward W, Middleton L, et al. The impact of pregnancy on breast cancer outcomes in women ≤35 years. Cancer. 2009; 115(6): 1174–1184.
- Sullivan M, Patel A, Wang J, et al. Molecular Subtype Distribution of Pregnancy-Associated Breast Cancer. Am J Clin Pathol. 2013; 140(suppl 1): A091–A091.
- Bae SY, Kim SJ, Lee J, et al. Clinical subtypes and prognosis of pregnancy-associated breast cancer: results from the Korean Breast Cancer Society Registry database. Breast Cancer Res Treat. 2018; 172(1): 113–121.
- Ruiz R, Herrero C, Strasser-Weippl K, et al. Epidemiology and pathophysiology of pregnancy-associated breast cancer: A review. Breast. 2017; 35: 136–141.
- Johansson ALV, Weibull CE, Fredriksson I, et al. Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact. Breast Cancer Res Treat. 2019; 174(2): 489–503.
- Taylor D, Lazberger J, Ives A, et al. Reducing delay in the diagnosis of pregnancy-associated breast cancer: how imaging can help us. J Med Imaging Radiat Oncol. 2011; 55(1): 33–42.
- Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg. 2003; 138(1): 91–8; discussion 99.
- Carmichael H, Matsen C, Freer P, et al. Breast cancer screening of pregnant and breastfeeding women with BRCA mutations. Breast Cancer Res Treat. 2017; 162(2): 225–230.
- Johansson A, Andersson TL, Hsieh CC, et al. Tumor characteristics and prognosis in women with pregnancy-associated breast cancer. Int J Cancer. 2017; 142(7): 1343–1354.
- Amant F, Loibl S, Neven P, et al. Breast cancer in pregnancy. The Lancet. 2012; 379(9815): 570–579.
- Kriege M, Brekelmans C, Boetes C, et al. Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition. N Engl J Med. 2004; 351(5): 427–437.
- Chen MM, Coakley FV, Kaimal A, et al. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008; 112(2 Pt 1): 333–340.
- Butler RS, Chen C, Vashi R, et al. Breast imaging of the pregnant and lactating patient: imaging modalities and pregnancy-associated breast cancer. AJR Am J Roentgenol. 2013; 200(2): 321–328.
- Bevers TB, Anderson BO, Bonaccio E, et al. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw. 2009; 7(10): 1060–1096.
- Robbins J, Jeffries D, Roubidoux M, et al. Accuracy of diagnostic mammography and breast ultrasound during pregnancy and lactation. AJR Am J Roentgenol. 2011; 196(3): 716–722.
- Azim HA, Santoro L, Pavlidis N, et al. Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies. Eur J Cancer. 2011; 47(1): 74–83.
- Clark R, Reid J. Carcinoma of the breast in pregnancy and lactation. Int J Radiat Oncol Biol Phys. 1978; 4(7-8): 693–698.
